CNSY Cerenome, Inc.
$2.33▼ -2.72%
Healthcare
Other
After hours
$2.34▲ +0.65%
Sep 11, 7:55 PM ET
Volume 78.7K
Avg Volume (10D) 66.2K
Key Metrics & Fundamentals
Market Cap
$17.65M
P/E Ratio
0.8
Div Yield
–%
52W Range
2.31 - 23.50
% vs 50 MA
-32.22%
% vs 200 MA
-65.41%
RSI-14
28.2
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.81
Free Cash Flow
-$7.63M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$8.86M
COGS
–
Operating Exp
$9.06M
Operating Income
-$9.06M
EBIT
-$9.06M
Pretax Income
-$9.01M
Net Income
-$9.01M
EPS (Diluted)
-1.31
Price & Volume History
Loading chart…
Recent News
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
GlobeNewswire · Sep 10, 2026 11:15 AM
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines
GlobeNewswire · Aug 20, 2026 11:30 AM
Cerenome Reports Second Quarter 2026 Financial Results and Business Update
GlobeNewswire · Aug 14, 2026 8:15 PM
Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives
GlobeNewswire · Aug 13, 2026 11:30 AM
Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform
GlobeNewswire · Aug 6, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CNSY's money flow as a full page
Social Sentiment
No Reddit posts found for CNSY.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.